Alain Moussy
26Patents
4h-index
20Co-inventors
59Inventor score
Filing activity: Jun 28, 2002 → Mar 24, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7718676B2 | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors | Chemistry; Metallurgy | 29 | Active |
| US10092564B2 | Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation | Human Necessities | 8 | Active |
| US7423055B2 | 2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases | Chemistry; Metallurgy | 6 | Expired |
| US8450302B2 | 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8153792B2 | Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors | Human Necessities | 1 | Active |
| US8492545B2 | Aminothiazole compounds as kinase inhibitors and methods of using the same | Human Necessities | 1 | Active |
| US8658659B2 | Substituted oxazole derivatives and their use as tyrosine kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7700610B2 | Use of tyrosine kinase inhibitors for treating allergic diseases | Physics | 1 | Expired |
| US7741335B2 | Use of tyrosine kinase inhibitors for treating inflammatory diseases | Physics | 0 | Expired |
| US8906357B2 | Treatment of multiple sclerosis with masitinib | Human Necessities | 0 | Active |
| US10045978B2 | Treatment of mastocytosis with masitinib | Human Necessities | 0 | Active |
| US10053455B2 | Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8993573B2 | 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8962665B2 | Thiazole and oxazole kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10392373B2 | Oxazole derivatives that inhibit Syk | Human Necessities | 0 | Active |
| US10570122B2 | Compounds with anti-tumoral activity | Chemistry; Metallurgy | 0 | Active |
| US8110591B2 | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10202370B2 | Benzimidazole derivatives as selective proteine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9168245B2 | Selective protein kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9078894B2 | Treatment of severe persistant asthma with masitinib | Human Necessities | 0 | Active |
| US7678805B2 | Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD) | Physics | 0 | Expired |
| US8227470B2 | Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors | Human Necessities | 0 | Active |
| US8940894B2 | Aminothiazole compounds as kinase inhibitors and methods of using the same | Human Necessities | 0 | Active |
| US7727731B2 | Potent, selective and non toxic c-kit inhibitors | Physics | 0 | Expired |
| US10238649B2 | Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.